help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-126-1-421
Endocrinology Vol. 126, No. 1 421-426
Copyright © 1990 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HOCK, J. M.
Right arrow Articles by CENTRELLA, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HOCK, J. M.
Right arrow Articles by CENTRELLA, M.

Transforming Growth Factor-β Stimulates Bone Matrix Apposition and Bone Cell Replication in Cultured Fetal Rat Calvariae*

JANET M. HOCK, ERNESTO CANALIS and MICHAEL CENTRELLA

Tufts University School of Dental Medicine and Veterans Administration Out-Patient Clinic Boston, Massachusetts 02043
Research Laboratory and Department of Medicine (Endocrine Section), Saint Francis Hospital and Medical Center Hartford, Connecticut 06105
the Department of Medicine, University of Connecticut Health Center Farmington, Connecticut, 06032

Address all correspondence and requests for reprints to: Dr. J. M. Hock, Department of General Dentistry, DHS-7, Tufts University School of Dental Medicine, Boston, Massachusetts 02043.

Abstract

Transforming growth factor-β (TGFβ) stimulates the expression of extracellular matrix proteins and may be a local regulator of bone growth. The aims of this research were to localize the effect of TGFjS on bone matrix formation and to determine if this effect was dependent on increased cell replication, using histomorphometry and autoradiography of bone organ cultures. Half-calvariae of 21-day-old fetal rats were cultured with native or recombinant TGFβ1 for 24 h and labeled either with [3H]proline for 0–24 or 24–48 h or with [3H]thymidine for the last 6 h of culture. Bones were fixed in glutaraldehyde, embedded in glycol methacrylate, and processed for autoradiography. Bone matrix formation was assessed as the matrix apposition rate per day and the percentage of [3H]proline-labeled bone surface. Cell replication was evaluated based on the number and percentage of [3H]thymidine labeled cells in the osteoblast cell zone, the osteoprogenitor cell zone, and the pericranial fibroblastic periosteum.

Both native and recombinant TGFβ at 1-30 ng/ml increased bone matrix formation by 25-40% (P < 0.05). At 30 ng/ml, TGFβ had a generalized mitogenic effect as cell replication increased by approximately 2-fold in all cell zones of the pericranial periosteum. TGFβ had specific effects on bone cell differentiation. The number of unlabeled cells lining the bone surface increased, and the number of osteoclasts on bone decreased. Inhibition of cell replication by hydroxyurea only partially blocked the stimulatory effect of TGFβ on bone matrix formation, suggesting that TGFβ may have independent effects on cell replication and differentiated bone cell function. In summary, TGFβ had a generalized mitogenic effect on the pericranial periosteum and specific stimulatory and inhibitory effects on bone cell differentiation and function. (Endocrinology 126: 421–426, 1990)

Footnotes

* This work was supported by NIDR Research Grant DE-07272 and a V.A. Research Associate Career Development Award (to J.M.H.) NIH Grant AR-39201 (to M.C.), and NIAMSD Grant AR-21707 (to E.C.). The research was carried out at the V.A. Medical Center (Newington, CT) and Saint Francis Hospital (Hartford, CT). These studies were presented in part at the Second Workshop on Cells and Cytokines in Bone and Cartilage, Davos, Switzerland, April 9-12, 1988.

Received July 27, 1989.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul
Transforming Growth Factor-{beta}1 to the Bone
Endocr. Rev., October 1, 2005; 26(6): 743 - 774.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
L. Lu, M. J. Yaszemski, and A. G. Mikos
TGF-{beta}1 Release from Biodegradable Polymer Microparticles: Its Effects on Marrow Stromal Osteoblast Function
J. Bone Joint Surg. Am., April 1, 2001; 83(90010): S82 - 92.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
L. Lu, M. J. Yaszemski, and A. G. Mikos
TGF-{beta}1 Release from Biodegradable Polymer Microparticles: Its Effects on Marrow Stromal Osteoblast Function
J. Bone Joint Surg. Am., April 1, 2001; 83(1_suppl_2): S82 - S92.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Kaneda, T. Nojima, M. Nakagawa, A. Ogasawara, H. Kaneko, T. Sato, H. Mano, M. Kumegawa, and Y. Hakeda
Endogenous Production of TGF-{beta} Is Essential for Osteoclastogenesis Induced by a Combination of Receptor Activator of NF-{kappa}B Ligand and Macrophage-Colony- Stimulating Factor
J. Immunol., October 15, 2000; 165(8): 4254 - 4263.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
T. J. Gal, T. Munoz-Antonia, C. A. Muro-Cacho, and D. W. Klotch
Radiation Effects on Osteoblasts In Vitro: A Potential Role in Osteoradionecrosis
Arch Otolaryngol Head Neck Surg, September 1, 2000; 126(9): 1124 - 1128.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Suzawa, Y. Takeuchi, S. Fukumoto, S. Kato, N. Ueno, K. Miyazono, T. Matsumoto, and T. Fujita
Extracellular Matrix-Associated Bone Morphogenetic Proteins Are Essential for Differentiation of Murine Osteoblastic Cells in Vitro
Endocrinology, May 1, 1999; 140(5): 2125 - 2133.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
E. Gazzerro, S. Rydziel, and E. Canalis
Skeletal Bone Morphogenetic Proteins Suppress the Expression of Collagenase-3 by Rat Osteoblasts
Endocrinology, February 1, 1999; 140(2): 562 - 567.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Dodig, MarkS. Kronenberg, A. Bedalov, BarbaraE. Kream, G. Gronowicz, StephenH. Clark, K. Mack, Y.-H. Liu, R. Maxon, Z. Pan, et al.
Identification of a TAAT-containing Motif Required for High Level Expression of the COL1A1 Promoter in Differentiated Osteoblasts of Transgenic Mice
J. Biol. Chem., July 5, 1996; 271(27): 16422 - 16429.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Takeuchi, K. Nakayama, and T. Matsumoto
Differentiation and Cell Surface Expression of Transforming Growth Factor-beta Receptors Are Regulated by Interaction with Matrix Collagen in Murine Osteoblastic Cells
J. Biol. Chem., February 16, 1996; 271(7): 3938 - 3944.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Critchlow, Y. Bland, and D. Ashhurst
The effects of age on the response of rabbit periosteal osteoprogenitor cells to exogenous transforming growth factor-beta 2
J. Cell Sci., January 2, 1994; 107(2): 499 - 516.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
T. Saito, A. Kinoshita, K.-i. Yoshiura, Y. Makita, K. Wakui, K. Honke, N. Niikawa, and N. Taniguchi
Domain-specific Mutations of a Transforming Growth Factor (TGF)-beta 1 Latency-associated Peptide Cause Camurati-Engelmann Disease Because of the Formation of a Constitutively Active Form of TGF-beta 1
J. Biol. Chem., April 6, 2001; 276(15): 11469 - 11472.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society